Condition

Stage IV Distal Bile Duct Cancer AJCC v8 clinical trials and research

Research outlook What's coming for Cholangiocarcinoma: the next 6 months to 5 years

As of November 12, 2026, Find a Trial lists 2 Stage IV Distal Bile Duct Cancer AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

All recruiting trials (2)

Related topics

Stage IV Intrahepatic Cholangiocarcinoma AJCC v8Gallbladder CarcinomaIntrahepatic CholangiocarcinomaLocally Advanced Intrahepatic CholangiocarcinomaMetastatic Biliary Tract CarcinomaMetastatic Malignant Neoplasm in the PeritoneumStage III Intrahepatic Cholangiocarcinoma AJCC v8Unresectable Biliary Tract CarcinomaUnresectable Intrahepatic CholangiocarcinomaDurvalumabPemigatinib

Quick answers

How many Stage IV Distal Bile Duct Cancer AJCC v8 clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.